Steven Herne Joins Unlearn’s Executive Team as Chief Commercial Officer
May 16 2024 - 11:01AM
Business Wire
Unlearn®, a leader in artificial intelligence research in
medicine, today announced the appointment of Steve Herne as its
first Chief Commercial Officer. Herne will spearhead commercial
strategies to propel the company’s growth following their
successful Series C funding.
"Things continue to move fast at Unlearn, and Steve’s proven
track record in healthcare innovation makes him the perfect leader
to shape our commercial strategy,” said Charles Fisher, Ph.D.,
founder and CEO of Unlearn.
Herne, with over 25 years of experience in the pharmaceutical
research and development market, has previously led long-term
strategic direction as Chief Commercial Officer at WCG and
Bioclinica. Herne's impressive career also includes leadership
positions at ERT, Icon Development Solutions, Covance, MDS Pharma
Services, and Inveresk Research.
"Unlearn is doing what others have tried for years – innovating
to overcome some of the biggest bottlenecks in clinical
development—that’s what excites me most,” said Herne. “I look
forward to driving the adoption of our groundbreaking solutions
using digital twins of clinical trial participants in clinical
research.”
About Unlearn
Unlearn is a pioneering artificial intelligence research company
that is revolutionizing clinical research with computational models
of patients called digital twins. Digital twins provide forecasts
of an individual’s health outcomes. They are used in Unlearn’s
Digital Twins Platform to help pharmaceutical and biotech companies
optimize clinical development and quickly and confidently produce
trustworthy outcomes. For more information, please visit
www.unlearn.ai or follow @UnlearnAI on Twitter/X and @unlearn-ai on
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240516144016/en/
Alyssa Horowitz unlearn@pancomm.com